[HTML][HTML] Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer
…, L Robles, C Grávalos, E González-Haba… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Adverse reactions to capecitabine-based chemotherapy limit full administration of cytotoxic
agents. Likewise, genetic variations associated with capecitabine-related adverse reactions …
agents. Likewise, genetic variations associated with capecitabine-related adverse reactions …
Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2− advanced or metastatic breast cancer in Spain
E Galve-Calvo, E González-Haba… - ClinicoEconomics …, 2018 - Taylor & Francis
Purpose The aim of this study was to evaluate the cost-effectiveness of ribociclib compared
to palbociclib, both in combination with letrozole, in the first-line treatment of …
to palbociclib, both in combination with letrozole, in the first-line treatment of …
Differential toxicity biomarkers for irinotecan-and oxaliplatin-containing chemotherapy in colorectal cancer
…, MI Garcia, P Garcia-Alfonso, E González-Haba… - Cancer chemotherapy …, 2013 - Springer
Purpose Oxaliplatin or irinotecan is usually administered jointly with fluoropyrimidines in
colorectal cancer patients treated with chemotherapy. Both drugs have different toxicity …
colorectal cancer patients treated with chemotherapy. Both drugs have different toxicity …
[HTML][HTML] The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study
…, JM Borrás, J Oliva-Moreno, E González-Haba… - The European Journal of …, 2019 - Springer
Objective To assess the economic burden of epithelial ovarian cancer (EOC) in incident
patients and the burden by disease stage in Spain. Methods We developed a Markov model …
patients and the burden by disease stage in Spain. Methods We developed a Markov model …
[HTML][HTML] Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy
…, JL Revuelta-Herrero, E González-Haba… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Objective The management of cardiotoxicity concerning the use of oral antineoplastic agents
(OAAs) is a challenge for healthcare professionals. Our objective was to create a …
(OAAs) is a challenge for healthcare professionals. Our objective was to create a …
Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain
LF Casado, A Burgos, E González-Haba… - ClinicoEconomics …, 2016 - Taylor & Francis
Objective To evaluate the cost-effectiveness of obinutuzumab in combination with
chlorambucil (GClb) versus rituximab plus chlorambucil (RClb) in the treatment of adults with …
chlorambucil (GClb) versus rituximab plus chlorambucil (RClb) in the treatment of adults with …
[HTML][HTML] Advances in transversal topics applicable to the care of bladder cancer patients in the real-world setting
…, R Gironés Sarrió, E González-Haba Peña… - Cancers, 2022 - mdpi.com
Simple Summary There are a number of scientific questions that are novel or controversial,
which are clinically relevant in the real-world setting for patients diagnosed with bladder …
which are clinically relevant in the real-world setting for patients diagnosed with bladder …
[HTML][HTML] Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus statement. Practice guidelines of the …
S Valero-García, E González-Haba… - Farmacia …, 2021 - Elsevier
Objective To establish a series of recommendations based on available evidence for
monitoring surface contamination in the areas devoted to compounding hazardous drugs in …
monitoring surface contamination in the areas devoted to compounding hazardous drugs in …
Aggressiveness of end-of-life cancer care: what happens in clinical practice?
…, J Valero-Salinas, E González-Haba… - Supportive Care in …, 2021 - Springer
Purpose End-of-life cancer care varies widely, and very few centers evaluate it
systematically. Our objective was to assess indicators of the aggressiveness of end-of-life …
systematically. Our objective was to assess indicators of the aggressiveness of end-of-life …
Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients' safety
…, E González-Haba… - Health Informatics …, 2020 - journals.sagepub.com
A failure modes, effects and criticality analysis was supported by an observational
medication error rate study to analyze the impact of Phocus Rx®, a new image-based …
medication error rate study to analyze the impact of Phocus Rx®, a new image-based …